Long-term outcome of childhood acute myeloid leukemia in a developing country: Experience from a children's hospital in China

Leukemia and Lymphoma

Volumn 51, Issue 12, 2010, Pages 2262-2269

  Xu, Xiao Jun ^a   Tang, Yong Min ^a   Song, Hua ^a   Yang, Shi Long ^a   Shi, Shu Wen ^a   Wei, Jian ^a  

^a CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

abandonment; Acute myeloid leukemia; child; developing country; outcome

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; HOMOHARRINGTONINE; METHOTREXATE; PACLITAXEL; RETINOIC ACID; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; APPENDICEAL ABSCESS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; BRAIN HEMORRHAGE; CANCER COMBINATION CHEMOTHERAPY; CARDIOMYOPATHY; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM METASTASIS; CHILD; CHILDHOOD LEUKEMIA; CHINA; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DEVELOPING COUNTRY; DIABETES MELLITUS; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG WITHDRAWAL; ESCHERICHIA COLI INFECTION; EVENT FREE SURVIVAL; FEMALE; GASTROINTESTINAL INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE INFECTION; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MYCOSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PEDIATRIC HOSPITAL; PERIANAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PSEUDOMONAS INFECTION; SKIN INFECTION; STAPHYLOCOCCUS INFECTION; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; TREATMENT REFUSAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; COHORT STUDIES; DEVELOPING COUNTRIES; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650040980     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.518653     Document Type: Article

References (23)

1. Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer 2006;107:2099-2107.
2. Chan LL, Abdel-Latif ME, Ariffin WA, Ariffin H, Lin HP. Treating childhood acute myeloid leukaemia with the AMLBFM- 83 protocol: experience in a developing country. Br J Haematol 2004;126:799-805.
3. Quintana J, Advis P, Becker A, et al. Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 results. Leukemia 2005;19:2143-2146.
4. Smith FO, Alonzo TA, Gerbing RB, Woods WG, Arceci RJ. Long-term results of children with acute myeloid leukemia: a report of three consecutive phase III trials by the Childrens Cancer Group: CCG 251, CCG 213 and CCG 2891. Leukemia 2005;19:2054-2062.
5. Ravindranath Y, Chang M, Steuber CP, et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005; 19:2101-2116.
6. CreutzigU, ZimmermannM, Ritter J, et al. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia 2005;19:2030-2042.
7. Gibson BE, Wheatley K, Hann IM, et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005;19:2130-2138.
8. Ribeiro RC, Rego E. Management of APL in developing countries: epidemiology, challenges and opportunities for international collaboration. Hematology Am Soc Hematol Educ Program 2006:162-168.
9. Capra M, Vilella L, Pereira WV, et al. Estimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil. Leuk Lymphoma 2007;48:2381-2386.
10. Biondi A, Rovelli A, Cantu-Rajnoldi A, et al. Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). Leukemia 1994;8:1264-1268.
11. Zou Y, Wang H, Chen XJ, et al. Study of clinical outcome and analysis of prognosis related factor in children with acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi 2006; 27:621-625. [in Chinese]
12. Li J, Gu LJ, Xue HL, et al. Response rate of AML-XH-99 protocol in the treatment of 82 childhood acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi 2004;25:351-354. [in Chinese]
13. Tang Y, Xu X, Song H, Yang S, Shi S, Wei J. Long-term outcome of childhood acute lymphoblastic leukemia treated in China. Pediatr Blood Cancer 2008;51:380-386.
14. Huang LB, Guan XQ, Zhang YC, Zhang XL, Ke ZY, Luo XQ. Current status of diagnosis and prognosis of infant acute leukemia in China. Pediatr Blood Cancer 2009;53:973-977.
15. Mostert S, Sitaresmi MN, Gundy CM, Janes V, Sutaryo, Veerman AJ. Comparing childhood leukaemia treatment before and after the introduction of a parental education programme in Indonesia. Arch Dis Child 2010;95:20-25.
16. Gu LJ, Li J, Xue HL, et al. Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China. Leuk Lymphoma 2008;49: 488-494.
17. Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia. J Clin Oncol 2005;23:9172-9178.
18. Arceci RJ. Progress and controversies in the treatment of pediatric acute myelogenous leukemia. Curr Opin Hematol 2002;9:353-360.
19. Ritter J, Creutzig U, Schellong G. Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-Group. Leukemia 1992;6(Suppl. 2):59-62.
20. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatmentrelated mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004;22: 4384-4393.
21. Rubnitz JE, Lensing S, Zhou Y, et al. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer 2004;101:1677-1684.
22. Gallegos-Castorena S, Medina-Sanson A, Gonzalez-Ramella O, Sanchez-Zubieta F, Martinez-Avalos A. Improved treatment results in Mexican children with acute myeloid leukemia using a Medical Research Council (MRC)-acute myeloid leukemia 10 modified protocol. Leuk Lymphoma 2009;50: 1132-1137.
23. Viana MB, Cunha KC, Ramos G, Murao M. Acute myeloid leukemia in childhood: fifteen-year experience in a single institution. J Pediatr (Rio) 2003;79:489-496.